Published in Medical Letter on the CDC and FDA, December 24th, 2006
"With the successful completion of this quarter, PHT continues to rewrite the ePRO industry's record books," said Phil Lee, PHT president and CEO. "Last year, our then-record Q3 led the exploding ePRO market with more than 20 new trials, 73% growth in bookings, the first trial in Japan, new Indic languages, and the first use of wirelessly integrated sensors with the PHT eSense PiKo.
"This year, we...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA